Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice

Oncotarget. 2018 May 22;9(39):25750. doi: 10.18632/oncotarget.22813.

Authors

Haobin Cai^{1

2}, Yijie Wang², Jiayang He², Tiantian Cai², Jun Wu², Jiansong Fang², Rong Zhang², Zhouke Guo¹, Li Guan², Qinkai Zhan², Li Lin³, Yao Xiao⁴, Huafeng Pan², Qi Wang²

Affiliations

¹ Department of Neurology & Psychology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518033, China.
² Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
³ Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
⁴ Guangzhou Medical University, Guangzhou 510182, China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.21515.].

Publication types

Published Erratum